An Observational Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer, Colon Cancer in the Adjuvant Setting, Advanced Gastric Cancer or Breast Cancer
Clinical trial NCT01664494 · COMPLETED
Trial details
- NCT number
- NCT01664494
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2010-04-01
- Primary completion
- 2012-07-01
- Enrollment
- 563
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.